Progress in Neuro-Psychopharmacology and Biological Psychiatry 1991-01-01

Studies on the properties of some peripheral MAO inhibitors.

E Scarr, P H Yu, B A Davis, A A Boulton

Index: Prog. Neuropsychopharmacol. Biol. Psychiatry 15 , 297, (1991)

Full Text: HTML

Abstract

1. Studies were carried out on three monoamine oxidase (MAO) inhibitors, two of which, debrisoquine and para- hydroxyphenelzine, are purported to be peripheral inhibitors and one, phenelzine, is a peripherally acting inhibitor, which has been included for comparitive purposes. 2. All three showed varying degrees of specificity towards MAO type A. 3. The action of debrisoquine was very rapid as was that of para- hydroxyphenelzine. 4. The inhibition caused by debrisoquine was competitive and reversible, while that caused by both phenelzine and para- hydroxyphenelzine was irreversible. 5. The inhibition caused by debrisoquine appeared to be unaffected by the pH of the medium.


Related Compounds

Related Articles:

Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma.

2015-01-01

[BMC Genomics 16 Suppl 1 , S1, (2015)]

A Comprehensive Metabolomic Investigation in Urine of Mice Exposed to Strontium-90.

2015-06-01

[Radiat. Res. 183 , 665-74, (2015)]

Global Metabolomic Identification of Long-Term Dose-Dependent Urinary Biomarkers in Nonhuman Primates Exposed to Ionizing Radiation.

2015-08-01

[Radiat. Res. 184 , 121-33, (2015)]

Development of a metabolomic radiation signature in urine from patients undergoing total body irradiation.

2014-04-01

[Radiat. Res. 181(4) , 350-61, (2014)]

Inactivation of Human Cytochrome P450 3A4 and 3A5 by Dronedarone and N-Desbutyl Dronedarone.

2016-01-01

[Mol. Pharmacol. 89 , 1-13, (2015)]

More Articles...